Examining the Effect of Lateralization Imagery Training on EEG Brain Oscillations in Individuals With Chronic Neck Pain
NCT06679335, Not applicable, Completed, Bahçeşehir University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Examining the Effect of Lateralization Imagery Training on EEG Brain Oscillations in Individuals With Chronic Neck Pain | ClinicalTrials.gov |
| NCT number | NCT06679335 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 34 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Bahçeşehir University | ClinicalTrials.gov |
| Conditions | Chronic Pain, Neck Pain | ClinicalTrials.gov |
| Interventions | Lateralization Imagery Training | ClinicalTrials.gov |
| First posted | 2024-11-07 | ClinicalTrials.gov |
| Last updated | 2025-12-09 | ClinicalTrials.gov |
Registered outcomes 9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Cognitive Status Assessment (Montreal Cognitive Assessment: MoCA) | Baseline | It will be used to evaluate the cognitive status of individuals and to exclude participants from the study. It is a test that aims to evaluate participants in 7 cognitive aspects such as attention, concentration, memory, language, calculation, spatial-visual skills, reasoning and orientation. It takes approximately ten minutes. The highest score that can be obtained from the test is 30. The cognitive level of the participant who scores 21 points or above is considered normal. Turkish validity-reliability study was conducted by Özdilek and Kenangil in 2014. | ClinicalTrials.gov |
| Primary | Stroop test (quick) | Baseline, and up to 4 weeks | It is a cognitive control test consisting of three parts developed by J. R. Stroop in 1935. The Stroop task and related tests are considered the gold standard of attention measurements in the literature. In the first part of the test, subjects are presented with color names and asked to read them as quickly as possible. In the second part, you are asked to say the colors of dot clusters printed with colored ink as quickly as possible. In the third part, the students are asked to read the words written in ink of a different color than the name of the presented color as quickly (and loudly) as possible. The Turkish validity and reliability study was conducted by Karakaş et al. in 1999. | ClinicalTrials.gov |
| Primary | Motor Imagery Assessment | Baseline | Made using the Movement Imagery Questionnaire-3. The Turkish validity and reliability study of the questionnaire was conducted by Dilek et al. It was made by. It consists of 3 subscales and a total of 12 items that evaluate external visual imagery, internal visual imagery, and kinesthetic imagery. Each of the 12 tasks in the survey is first performed physically, then the participant returns to the starting position and imagery is performed according to the desired type of imagery. Scoring is made between 1 and 7, with "1 point: very difficult to see/feel, 7 points: very easy to see/feel." When calculating the score, internal visual imagery, external visual imagery and kinesthetic imagery scores are added separately, divided by 4 and averaged to obtain the score of each subscale. | ClinicalTrials.gov |
| Primary | Pain Intensity | Baseline, and up to 4 weeks | Individuals' pain intensity will be evaluated subjectively with the Visual Analog Scale (VAS). This scale consists of a 10 cm linear line. The starting point of the line is 0, no pain; The endpoint of 10 is the worst pain ever experienced in life; 5 indicates moderate pain. People will be asked to numerically rate the severity of their pain on the scale. | ClinicalTrials.gov |
| Primary | Kinesiophobia Assessment | Baseline, and up to 4 weeks | Fear of movement will be evaluated with the TAMPA kinesiophobia scale (TKÖ). TAS is a questionnaire consisting of 17 questions developed by Korietal in 1991 for musculoskeletal pain. This scale includes parameters for injury/re-injury and fear avoidance in activities related to . In this scale, each question was scored as (1 = disagree, 4 = strongly agree). While scoring, items 4, 8, 12 and 16 are reversed and then the total score is obtained. The person receives a total score between 17-68. The Turkish reliability of the Tampa Kinesiophobia Scale was conducted by Yılmaz et al. | ClinicalTrials.gov |
| Primary | Evaluation of Neck Disability | Baseline, and up to 4 weeks | The extent to which individuals' chronic neck pain affects their daily living activities will be evaluated with the Neck Disability Index (NEI). The Turkish validity and reliability of the index was determined by Telci et al. The index, which evaluates subjective symptoms and activities of daily living, consists of a total of 10 sections (pain intensity, personal care, lifting, reading, headache, concentration, work life, driving, sleep and leisure activities). There are 6 options for each section, ranging from 0 to 5 points. The total score varies between 0 and 50 (0: no disability; 50: maximum disability), and an increase in the total score indicates that the disability increases. In the evaluation in our study, the percentage of each score will be calculated to obtain an equal score distribution in case the patients do not answer some questions. 8 percent and below is considered "no excuse". | ClinicalTrials.gov |
| Primary | Proprioception Sense Test | Baseline, and up to 4 weeks | Cervical joint position error will be measured using the Dualer IQ digital inclinometer (J-Tech Medical, Midvale, UT, USA). Digital inclinometer spine assessment protocols are well established and approved by the American Medical Association. Digital inclinometer allows clinicians to evaluate range of motion and proprioception using dynamic inclinometry similar to that used in other goniometric protocols. Digital inclinometer has demonstrated test-retest reliability for measuring spinal range of motion. | ClinicalTrials.gov |
| Primary | Body Awareness Assessment | Baseline, and up to 4 weeks | Individuals' neck awareness will be assessed with the Fremantle Neck Awareness Questionnaire. Developed by Benedict Wand, its Turkish validity and reliability were confirmed by Onan et al. Likert type assessing individual-specific altered perception (0 = I never/never feel like this, 1= I rarely feel like this, 2 = Sometimes, or some of the time I feel like this, 3 = I often feel like this, 4 = I always or most of the time feel like this) It is a simple survey. The survey asks individuals 9 questions, such as how they perceive their neck in relation to their body and how they perceive their body position. | ClinicalTrials.gov |
| Primary | EEG power in alpha, theta, beta band | Baseline, and up to 4 weeks | Evaluation of brain oscillations with EEG analysis. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 36
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 686873 | BACKGROUND | PubMed |
| 10025021 | BACKGROUND | PubMed |
| 10913710 | BACKGROUND | PubMed |
| 11673934 | BACKGROUND | PubMed |
| 12221179 | BACKGROUND | PubMed |
| 14670576 | BACKGROUND | PubMed |
| 15166100 | BACKGROUND | PubMed |
| 15210879 | BACKGROUND | PubMed |
| 15817019 | BACKGROUND | PubMed |
| 16792279 | BACKGROUND | PubMed |
| 17082465 | BACKGROUND | PubMed |
| 17702636 | BACKGROUND | PubMed |
| 18180194 | BACKGROUND | PubMed |
| 18204400 | BACKGROUND | PubMed |
| 19770615 | BACKGROUND | PubMed |
| 21234168 | BACKGROUND | PubMed |
| 21306870 | BACKGROUND | PubMed |
| 23357411 | BACKGROUND | PubMed |
| 23583615 | BACKGROUND | PubMed |
| 24176780 | BACKGROUND | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)